Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-18-036606

Director sold 4,329 shares at $103.02 ($445,974)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
GELBMAN RONALD G Director 2018-12-14 Sale −4,329 $103.02 $445,974 53,062 D: show line 1 in the form
Open-market sales · 4,329 sh · avg $103.02 · $445,974
Loading xslF345X03/form4.xml…